Abstract

BackgroundAttentional complaints are common in narcolepsy patients and can overlap with daytime sleepiness features. Few studies attempted to characterize attentional domains in narcolepsy leading to controversial results. We aimed to assess the impact of hypocretin deficiency on attentional functioning by comparing performances on the attention network test (ANT) of narcoleptic patients with hypocretin deficiency (narcolepsy type 1—NT1) versus patients without hypocretin deficiency (narcolepsy type 2—NT2) and healthy controls. We also addressed frequency and severity of psychopathological symptoms and their influence on performances on ANT.MethodsTwenty-one NT1 patients, fifteen NT2 patients and twenty-two healthy controls underwent the ANT, which allows assessing three separate attentional processes (alerting, orienting and executive control), and a psychometric assessment including questionnaires on attention-deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder, anxiety and depression symptoms.ResultsNT1 and NT2 patients presented with slower reaction times compared to controls. NT1 patients exhibited an impairment of alerting network relative to NT2 and healthy controls, while orienting and executive control networks efficiency were comparable between groups. NT1 and NT2 displayed higher severity of ADHD inattentive domain than controls, NT1 patients also displayed higher severity of ADHD hyperactive domain and depressive symptoms. In NT1, ADHD and depressive symptoms were positively correlated.ConclusionsDespite a shared slowing of reaction times in both NT1 and NT2, a selective impairment of alerting network was present only in hypocretin deficient patients. Clinicians should carefully consider attentional deficits and psychopathological symptoms, including ADHD symptoms, in the clinical assessment and management of patients with narcolepsy.

Highlights

  • Narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2) are two central disorders of hypersomnolence characterized by chronic hypersomnolence with sleep onset typically showing a rapid transitions into rapid eye movement (REM) sleep, along with additional untimely manifestations of dissociated REM sleep [1]

  • We aimed to assess the impact of hypocretin deficiency on attentional functioning by comparing performances on the attention network test (ANT) of narcoleptic patients with hypocretin deficiency versus patients without hypocretin deficiency and healthy controls

  • NT1 and NT2 patients presented with slower reaction times compared to controls

Read more

Summary

Introduction

Narcolepsy type 1 (NT1) and narcolepsy type 2 (NT2) are two central disorders of hypersomnolence characterized by chronic hypersomnolence with sleep onset typically showing a rapid transitions into rapid eye movement (REM) sleep, along with additional untimely manifestations of dissociated REM sleep (hypnagogic/hypnopompic hallucinations, sleep paralysis) [1]. NT1, is characterized by cataplexy (sudden loss of muscle tone during wakefulness, triggered by emotions), and has a firmly established pathophysiology linked to the loss of hypothalamic hypocretin-producing neurons [1,2]. This deficit was shown in post-mortem studies and is mirrored by reduced or absent hypocretin-1 (Hcrt-1) levels in the cerebrospinal fluid (CFS), making NT1 a hypocretin deficiency syndrome [3,4]. We aimed to assess the impact of hypocretin deficiency on attentional functioning by comparing performances on the attention network test (ANT) of narcoleptic patients with hypocretin deficiency (narcolepsy type 1—NT1) versus patients without hypocretin deficiency (narcolepsy type 2—NT2) and healthy controls. We addressed frequency and severity of psychopathological symptoms and their influence on performances on ANT

Objectives
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call